Hypodontia as a risk marker for epithelial ovarian cancer: a case-controlled study.

BACKGROUND Genetic mutations that result in hypodontia also may be associated with abnormalities in other parts of the body. The authors conducted a study to establish the prevalence rates of hypodontia among subjects with epithelial ovarian cancer (EOC) and control subjects to explore possible genetic associations between these two phenotypes. METHODS The authors recruited 50 subjects with EOC and 100 control subjects who did not have EOC. The authors performed a dental examination on each subject to detect hypodontia, and they reviewed pertinent radiographs and dental histories. They also recorded any family history of cancer and hypodontia. RESULTS The prevalence of hypodontia was 20 percent for EOC subjects and 3 percent for control subjects. The difference between these two hypodontia rates was significant. This difference implied that women with EOC are 8.1 times more likely to have hypodontia than are women without EOC. The severity of hypodontia was similar between the two groups, with one to two teeth being affected. Maxillary lateral incisors followed by second premolars were the most frequently affected teeth. CONCLUSION The preliminary data suggest a statistical association between hypodontia of the permanent dentition and EOC. CLINICAL IMPLICATIONS Genetic analysis of the genes of interest is necessary to explore similarities between hypodontia and EOC further. An association could allow hypodontia to serve as a potential risk marker for EOC.

[1]  Molly Brewer,et al.  Prevention and early detection of ovarian cancer: mission impossible? , 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[2]  I. Thesleff,et al.  The genetic basis of tooth development and dental defects , 2006, American journal of medical genetics. Part A.

[3]  P. Jagodziński,et al.  Axis inhibition protein 2 (AXIN2) polymorphisms may be a risk factor for selective tooth agenesis , 2006, Journal of Human Genetics.

[4]  H. Naora,et al.  Homeobox gene expression in cancer: insights from developmental regulation and deregulation. , 2005, European journal of cancer.

[5]  P. Mossey,et al.  Hypodontia--a retrospective review of prevalence and etiology. Part I. , 2005, Quintessence international.

[6]  J. Woodgett,et al.  The links between axin and carcinogenesis , 2005, Journal of Clinical Pathology.

[7]  Kyusam Choi,et al.  Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. , 2005, Cancer research.

[8]  M. Klein,et al.  Novel Mutation of the Initiation Codon of PAX9 Causes Oligodontia , 2005, Journal of dental research.

[9]  F. Javier.,et al.  Agenesias dentarias: en busca de las alteraciones genéticas responsables de la falta de desarrollo , 2004 .

[10]  Francisco Javier Kolenc-Fusé.  Tooth agenesis: in search of mutations behind failed dental development. , 2004, Medicina Oral.

[11]  I. Thesleff,et al.  Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. , 2004, American journal of human genetics.

[12]  L. Dermaut,et al.  Has hypodontia increased in Caucasians during the 20th century? A meta-analysis. , 2004, European journal of orthodontics.

[13]  J. Seidman,et al.  A novel missense mutation in the paired domain of PAX9 causes non-syndromic oligodontia , 2004, Human Genetics.

[14]  W. Trzeciak,et al.  Molecular basis of non-syndromic tooth agenesis: mutations of MSX1 and PAX9 reflect their role in patterning human dentition. , 2003, European journal of oral sciences.

[15]  Kathleen R. Cho,et al.  Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. , 2003, Cancer research.

[16]  F. Nunes,et al.  Homeobox genes: a molecular link between development and cancer. , 2003, Pesquisa odontologica brasileira = Brazilian oral research.

[17]  Yipingchen,et al.  Msx homeobox gene family and craniofacial development , 2003 .

[18]  M. Kataja,et al.  Concomitant occurrence of canine malposition and tooth agenesis: evidence of orofacial genetic fields. , 2002, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

[19]  H. Höfler,et al.  Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus , 2002, The Journal of pathology.

[20]  Kathleen R. Cho,et al.  Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. , 2002, The Journal of biological chemistry.

[21]  A. Lidral,et al.  The Role of MSX1 in Human Tooth Agenesis , 2002, Journal of dental research.

[22]  D. Milewicz,et al.  A Novel Mutation in Human PAX9 Causes Molar Oligodontia , 2002 .

[23]  D. Milewicz,et al.  A novel mutation in human PAX9 causes molar oligodontia. , 2002, Journal of dental research.

[24]  Kathleen R. Cho,et al.  Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. , 2001, Cancer research.

[25]  D. Porteous,et al.  BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression. , 2001, Cancer research.

[26]  J. Lee,et al.  Msx1 gene overexpression induces G1 phase cell arrest in human ovarian cancer cell line OVCAR3. , 2001, Biochemical and biophysical research communications.

[27]  H. Vastardis.  The genetics of human tooth agenesis: new discoveries for understanding dental anomalies. , 2000, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

[28]  F. Beemer,et al.  MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans , 2000, Nature Genetics.

[29]  David I. Smith,et al.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling (vol 26, pg 146, 2000) , 2000 .

[30]  P. Patel,et al.  Mutation of PAX9 is associated with oligodontia , 2000, Nature Genetics.

[31]  R. Balling,et al.  Teeth. Where and how to make them. , 1999, Trends in genetics : TIG.

[32]  I. Thesleff.  The genetic basis of normal and abnormal craniofacial development. , 1998, Acta odontologica Scandinavica.

[33]  G. Edelman,et al.  Barx2, a new homeobox gene of the Bar class, is expressed in neural and craniofacial structures during development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Maas,et al.  Msx1 controls inductive signaling in mammalian tooth morphogenesis. , 1996, Development.

[35]  J. Seidman,et al.  A human MSX1 homeodomain missense mutation causes selective tooth agenesis , 1996, Nature Genetics.

[36]  I. Thesleff.  Homeobox genes and growth factors in regulation of craniofacial and tooth morphogenesis. , 1995, Acta odontologica Scandinavica.

[37]  A H Brook,et al.  A unifying aetiological explanation for anomalies of human tooth number and size. , 1984, Archives of oral biology.